Art

J-GLOBAL ID：201802267678518775   Reference number：18A1804170

Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m²) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer

HER2陰性乳癌に対するネオアジュバント化学療法としての毎週のナノ粒子アルブミン結合パクリタキセル(150mg/m2)とそれに続くフルオロウラシル,エピルビシンおよびシクロホスファミド療法の実現可能性研究【JST・京大機械翻訳】

Author (8)： Kojima Yasuyuki (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Kawamoto Hisanori (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Nishikawa Toru (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Hayami Ryosuke (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Shimo Arata (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Haku Ei (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Akiyama Kyoko (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan) ,  Tsugawa Koichiro (Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
Material： Clinical Breast Cancer
Volume： 18  Issue： 5  Page： 374-379  Publication year： 2018 
JST Material Number： W3206A  ISSN： 1526-8209  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Although several studies have ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1804170&from=J-GLOBAL&jstjournalNo=W3206A") }}

Thesaurus term： *breast tumor ,  confidence interval ,  *albumin ,  neuropathy ,  patient ,  *drug therapy ,  *therapy ,  *nano particle ,  Neutropenia ,  adverse reaction ,  amine ,  nitrogen heterocyclic compound ,  oxygen heterocyclic compound ,  organochlorine compound ,  inorganic acid ester ,  phosphorus heterocyclic compound ,  amino sugar ,  quinone ,  glycoside (except carbohydrate) ,  polyphenol ,  deoxysugar ,  pyranoside ,  phenol ether ,  polynuclear aromatic compound ,  hydroxy ketone ,  polyol ,  organofluorine compound ,  urea compound ,  hydroxy compound
Semi thesaurus term： ネオアジュバンド療法 ,  有害事象 ,  レジメン , 【Automatic Indexing@JST】

Author keywords (5)： Breast cancer ,  Nab-paclitaxel ,  Neoadjuvant chemotherapy ,  Peripheral neuropathy ,  Phase II

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Cyclophosphamid ,  Epirubicin ,  Fluorouracil

Terms in the title (9)： HER2陰性乳癌 ,  ネオアジュバント化学療法 ,  ナノ粒子アルブミン結合パクリタキセル ,  フルオロウラシル ,  エピルビシン ,  シクロホスファミド ,  療法 ,  実現可能性 ,  研究